Tyra Biosciences (TYRA) Balance Sheet: Assets & Liabilities

Tyra Biosciences (TYRA) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Tyra Biosciences reported total assets of $282.61M and total liabilities of $23.43M. Shareholders' equity was $259.18M, down 24.5% from $343.15M a year earlier. Total debt stood at $5.81M against $256.00M in cash and short-term investments, a net cash position of $250.19M. That puts debt-to-equity at 0.02, compared with 0.02 a year earlier.

Tyra Biosciences Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Tyra Biosciences, Inc. (TYRA) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
Current Assets
Cash and Cash Equivalents	77.39	91.97	58.01	251.21	302.18	15.22	0.11
Short-Term Investments	178.62	249.48	145.46	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	256.00	341.44	203.47	251.21	302.18	15.22	0.11
Accounts Receivable	0.00	2.00	0.70	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	9.45	6.02	8.20	6.08	1.88	0.06	0.02
Total Current Assets	265.45	347.46	211.67	257.29	304.06	15.28	0.13
Non-Current Assets
Property, Plant & Equipment (Net)	6.89	7.72	8.15	3.54	2.09	0.47	0.28
Long-Term Investments	0.00	0.00	0.00	0.00	0.00	0.24	0.00
Other Non-Current Assets	10.27	8.38	6.03	5.35	0.56	0.26	0.13
Total Non-Current Assets	17.16	16.10	14.19	8.89	2.64	0.73	0.40
Total Assets	282.61	363.56	225.86	266.18	306.70	16.01	0.53
Current Liabilities
Accounts Payable	1.18	0.59	4.66	1.15	0.60	0.66	0.33
Short-Term Debt	0.47	0.41	0.28	0.14	0.20	0.14	0.14
Accrued Liabilities	16.44	13.59	10.39	4.42	2.82	1.05	-
Other Current Liabilities	16.44	13.59	10.39	4.42	2.82	1.05	4.69
Total Current Liabilities	18.09	14.59	15.33	5.70	3.62	1.86	5.16
Non-Current Liabilities
Long-Term Debt	5.34	5.81	6.22	2.48	0.98	0.00	0.11
Other Non-Current Liabilities	0.00	0.00	0.05	0.17	0.37	0.14	0.00
Total Non-Current Liabilities	5.34	5.81	6.26	2.65	1.35	27.79	0.11
Total Liabilities	23.43	20.41	21.60	8.35	4.96	2.00	5.27
Stockholders' Equity
Common Stock	0.01	0.01	0.00	0.00	0.00	0.00	0.00
Retained Earnings	-371.26	-251.31	-164.83	-95.70	-40.37	-14.08	-4.74
Accumulated Other Comprehensive Income	0.39	0.77	0.38	0.00	0.00	0.00	0.00
Additional Paid-in Capital	630.04	593.69	368.71	353.52	342.10	0.44	0.00
Shares Outstanding	53.71	50.75	43.02	42.35	41.44	-	-
Total Stockholders' Equity	259.18	343.15	204.26	257.83	301.74	14.01	-4.74
Total Liabilities & Equity	282.61	363.56	225.86	266.18	306.70	16.01	0.53

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Tyra Biosciences Balance Sheet

How much debt does Tyra Biosciences have?

Tyra Biosciences had total debt of $5.81M as of Dec 31, 2025, against $256.00M in cash and short-term investments. Its debt-to-equity ratio was 0.02. Total debt was $6.22M a year earlier.

What are Tyra Biosciences's total assets?

Tyra Biosciences reported total assets of $282.61M as of Dec 31, 2025, down 22.3% from $363.56M a year earlier. Total liabilities were $23.43M.

What is Tyra Biosciences's shareholders' equity?

Tyra Biosciences's shareholders' equity was $259.18M as of Dec 31, 2025, or about $4.83 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition